VIA
HEPA

Vantage Investment Advisors’s Hepion Pharmaceuticals HEPA Stock Holding History

Vantage Investment Advisors’s Portfolio HEPA Stock Details HEPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Hold
0
– – – 777
2018
Q2 		– Hold
0
– – – 784
2018
Q1 		– Hold
0
– – – 821
2017
Q4 		– Hold
0
– – – 833
2017
Q3 		– Hold
0
– – – 767
2017
Q2 		– Hold
0
– – – 740
2017
Q1 		– Hold
0
– – – 700
2016
Q4 		– Hold
0
– – – 750
2016
Q3 		– Hold
0
– – – 734
2016
Q2 		– Hold
0
– – – 768
2016
Q1 		– Hold
0
– – – 756
2015
Q4 		– Hold
0
– – – 696
2015
Q3 		– Hold
0
– – – 705
2015
Q2 		– Hold
0
– – – 602
2015
Q1 		– Hold
0
– – – 736

Other funds holding HEPA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return